Kataria S, Juneja D, Singh O. Transient elastography (FibroScan) in critical care: Applications and limitations. World J Meta-Anal 2023; 11(7): 340-350 [DOI: 10.13105/wjma.v11.i7.340]
Corresponding Author of This Article
Deven Juneja, DNB, MBBS, Director, Department of Critical Care Medicine, Max Super Speciality Hospital, 1 Press Enclave Road, Saket, New Delhi 110017, India. devenjuneja@gmail.com
Research Domain of This Article
Critical Care Medicine
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Meta-Anal. Dec 18, 2023; 11(7): 340-350 Published online Dec 18, 2023. doi: 10.13105/wjma.v11.i7.340
Transient elastography (FibroScan) in critical care: Applications and limitations
Sahil Kataria, Deven Juneja, Omender Singh
Sahil Kataria, Department of Critical Care Medicine, Holy Family Hospital, New Delhi 110025, India
Deven Juneja, Omender Singh, Department of Critical Care Medicine, Max Super Speciality Hospital, New Delhi 110017, India
Author contributions: Kataria S and Juneja D researched the subject, performed data accusation, and performed the majority of the writing; Singh O provided inputs in paper writing and reviewed the final draft.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Deven Juneja, DNB, MBBS, Director, Department of Critical Care Medicine, Max Super Speciality Hospital, 1 Press Enclave Road, Saket, New Delhi 110017, India. devenjuneja@gmail.com
Received: July 28, 2023 Peer-review started: July 28, 2023 First decision: August 10, 2023 Revised: August 28, 2023 Accepted: September 22, 2023 Article in press: September 22, 2023 Published online: December 18, 2023 Processing time: 138 Days and 14.9 Hours
Core Tip
Core Tip: Liver dysfunction is common in critically ill patients. For diagnosis, severity assessment, and prognostication of liver fibrosis, liver biopsy is considered the gold standard. However, because of inherent risks associated with the invasive nature of liver biopsy, non-invasive tests may be preferable in intensive care unit patients. Serology markers for liver fibrosis lack specificity and accuracy and hence newer tests like liver stiffness measurement (LSM) are increasingly been used in these patients. Transient elastography using FibroScan is arguably the most commonly employed and validated tool for LSM. FibroScan has been used in the management, prediction of complications, and prognostication of various liver diseases including acute and chronic conditions. However, there are several integral limitations which should be considered while applying this test in critically ill patients.
